Swiss Life Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$17.3M |
| 2 |
Cisco
CSCO
|
+$12.9M |
| 3 |
Procter & Gamble
PG
|
+$12.7M |
| 4 |
NVIDIA
NVDA
|
+$12.6M |
| 5 |
Accenture
ACN
|
+$12.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$89.9M |
| 2 |
Chevron
CVX
|
+$26.7M |
| 3 |
Home Depot
HD
|
+$16.5M |
| 4 |
ConocoPhillips
COP
|
+$15.7M |
| 5 |
Eli Lilly
LLY
|
+$15.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.07% |
| 2 | Healthcare | 13.92% |
| 3 | Financials | 10.93% |
| 4 | Industrials | 9.25% |
| 5 | Consumer Discretionary | 8.91% |
Similar funds
Swiss Life Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, Swiss Life Asset Management held 652 positions worth $6.65B, up 11% from $5.99B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss Life Asset Management deployed $336M of net new capital in Q1 2023, opening 57 new positions and adding to 346 existing holdings. Its largest new stake was Zimmer Biomet: 81,015 shares worth $10.5M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $89.9M trimmed.
- Swiss Life Asset Management's largest Q1 2023 buy was Zimmer Biomet: 81,015 shares worth $10.5M.
- Swiss Life Asset Management added most to Apple in Q1 2023, an estimated $17.3M increase.
- Swiss Life Asset Management's biggest Q1 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $89.9M.
- Swiss Life Asset Management fully exited M&T Bank in Q1 2023, selling an estimated $6.64M.
- Swiss Life Asset Management's ten largest holdings make up 24% of its $6.65B portfolio in Q1 2023.
- Swiss Life Asset Management opened 57 new positions and closed 47 in Q1 2023.
- Swiss Life Asset Management's portfolio value rose 11% quarter-over-quarter to $6.65B.
Based on Swiss Life Asset Management's 13F filing for Q1 2023, filed 9 Dec 2025.